Cargando…
Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion
OBJECTIVE: It is well known that atherosclerotic inflammatory vascular disease is critically driven by oxidized lipids and cytokines. In this regard, tumor necrosis factor (TNF)-α is known as a crucial mediator of early pro-atherosclerotic events. Epidemiologic data suggest that blockade of TNF-α ha...
Autores principales: | Oberoi, Raghav, Schuett, Jutta, Schuett, Harald, Koch, Ann-Kathrin, Luchtefeld, Maren, Grote, Karsten, Schieffer, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965117/ https://www.ncbi.nlm.nih.gov/pubmed/27467817 http://dx.doi.org/10.1371/journal.pone.0160145 |
Ejemplares similares
-
Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease
por: Oberoi, Raghav, et al.
Publicado: (2015) -
Identification of microRNAs involved in NOD-dependent induction of pro-inflammatory genes in pulmonary endothelial cells
por: Vlacil, Ann-Kathrin, et al.
Publicado: (2020) -
Anti-Inflammatory Effects of C1q/Tumor Necrosis Factor-Related Protein 3 (CTRP3) in Endothelial Cells
por: Schmid, Andreas, et al.
Publicado: (2021) -
Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis
por: Vlacil, Ann-Kathrin, et al.
Publicado: (2020) -
Role of Suppressor of Cytokine Signaling-1 In Murine Atherosclerosis
por: Grothusen, Christina, et al.
Publicado: (2012)